What's driving this
59 ng/dL, top of range — the enclomiphene-driven T rise pulls DHT up with it. Relevant to hair, but it validates the topical-antiandrogen + no-finasteride strategy: systemic 5-AR inhibition stays off the table while TTC.
Full protocol →| Draw | Value | Status |
|---|---|---|
| June 25, 2026 | 59 ng/dL | NORMAL |